Finance

Beta
Lists
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$2.05
+12.02%
(+0.22) 1D
$2.05
0.00% (0.00)
Pre-market
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALDX...
Open
$1.84
High
$2.08
Low
$1.82
Mkt. cap
123.66M
Avg. vol.
1.38M
Volume
400.00
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.46
Beta
1.19
Shares outstanding
60.32M
No. of employees
7
Open
$1.84
High
$2.08
Low
$1.82
Mkt. cap
123.66M
Avg. vol.
1.38M
Volume
400.00
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.46
Beta
1.19
Shares outstanding
60.32M
No. of employees
7
News stories
From sources across the web
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees7
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com
Analyst ratings
Based on 1 analyst giving stock ratings to ALDX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ALDX in the last 3 months
Highest
Current $2.05
$2.00 (-2.44%)
Average
$2.00 (-2.44%)
Lowest
$2.00 (-2.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Hold
Reiterated
$2.00
-2.4%
05/11/2026
Thomas Shrader
BTIG
Buy
Maintained
$9.00
+339%
03/17/2026
Clara Dong
Jefferies
Buy
Maintained
$7.00
+241.5%
10/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.51M
5.43M
4.30M
2.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
2.57M
2.36M
1.14M
Operating expense
10.17M
8.00M
6.67M
3.55M
Total operating expenses
10.17M
8.00M
6.67M
3.55M
Operating income
-10.17M
-8.00M
-6.67M
-3.55M
Other non operating income
-
-
-
-
EBT including unusual items
-9.77M
-7.69M
-6.46M
-3.45M
EBT excluding unusual items
-9.77M
-7.69M
-6.46M
-3.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.77M
-7.69M
-6.46M
-3.45M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.13
-0.10
-0.06
Interest and investment income
872.04K
788.69K
681.64K
562.98K
Interest expense
-470.62K
-475.90K
-475.26K
-468.68K
Net interest expenses
401.42K
312.79K
206.38K
94.30K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.11M
-7.94M
-6.60M
-3.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer